Clinical Research Enhancement Act of 1996

Summary

Clinical Research Enhancement Act of 1996 - Amends the Public Health Service Act to direct the President to establish the President's Clinical Research Panel, as part of the Office of Science and Technology Policy (OSTP), to evaluate the status of the U.S. clinical research environment. Authorizes appropriations. Requires the Advisory Committee to the Director (of the National Institutes of Health (NIH)) on Clinical Research to report to the Director and to the Panel and to implement recommendations as the Committee determines necessary to remedy NIH clinical research deficiencies. Terminates the Committee five years after enactment of this Act. Requires the OSTP to review the compositions, functions, and outcomes of study section activities at all Federal agencies as such activities relate to clinical research proposals for investigator-initiated support. Authorizes appropriations. Requires the Director to: (1) support and expand NIH's clinical research involvement; (2) support and expand available resources; and (3) establish certain peer review mechanisms. Mandates grants for: (1) the establishment of general clinical research centers to provide the infrastructure for clinical research training and career enhancement; (2) clinical research career enhancement awards; and (3) innovative medical science awards to support individual clinical research projects. Authorizes appropriations. Increases the maximum aggregate number of contracts that may be made under existing provisions relating to: (1) undergraduate scholarships regarding professions needed by NIH; and (2) loan repayments regarding clinical researchers (currently, clinical researchers from disadvantaged backgrounds). Authorizes appropriations for the loan repayment program. Requires that at least 50 percent of such funds for a fiscal year be used for contracts with qualified health professionals from disadvantaged backgrounds.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 25 July 1996

   Introduced

   Referred to the House Committee on Commerce.

   Source: IntroReferral

2. 25 July 1996

   Introduced

   Introduced in House

   Source: IntroReferral

3. 25 July 1996

   Introduced

   Introduced in House

   Source: IntroReferral

4. 9 August 1996

   Referred

   Referred to the Subcommittee on Health and Environment.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 25 July 1996 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 25 July 1996

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 25 July 1996

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 25 July 1996

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Lowey, Nita M. [D-NY-17] · D · Sponsor
• Rep. Johnson, Nancy L. [R-CT-5] · R · Sponsor
• Sen. Durbin, Richard J. [D-IL] · D · Sponsor
• Rep. Hoyer, Steny H. [D-MD-5] · D · Sponsor
• Rep. Morella, Constance A. [R-MD-8] · R · Sponsor
• Rep. Leach, James A. [R-IA-2] · R · Sponsor
• Rep. Pelosi, Nancy [D-CA-11] · D · Sponsor
• Rep. Nadler, Jerrold [D-NY-12] · D · Sponsor
• Rep. DeLauro, Rosa L. [D-CT-3] · D · Sponsor
• · hsif00 · Standing

Related records

No cross-record relationships stored yet.